User profiles for "author:Werner Poewe"

Werner Poewe

Professor Neurologie
Verified email at i-med.ac.at
Cited by 128468

MDS clinical diagnostic criteria for Parkinson's disease

RB Postuma, D Berg, M Stern, W Poewe… - Movement …, 2015 - Wiley Online Library
This document presents the Movement Disorder Society Clinical Diagnostic Criteria for
Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use …

Parkinson disease

W Poewe, K Seppi, CM Tanner, GM Halliday… - Nature reviews Disease …, 2017 - nature.com
Parkinson disease is the second-most common neurodegenerative disorder that affects 2–
3% of the population≥ 65 years of age. Neuronal loss in the substantia nigra, which causes …

Clinical diagnostic criteria for dementia associated with Parkinson's disease

M Emre, D Aarsland, R Brown, DJ Burn… - … : official journal of the …, 2007 - Wiley Online Library
Dementia has been increasingly more recognized to be a common feature in patients with
Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of …

Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria

GU Höglinger, G Respondek, M Stamelou… - Movement …, 2017 - Wiley Online Library
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria,
published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for …

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results

CG Goetz, BC Tilley, SR Shaftman… - … : official journal of the …, 2008 - Wiley Online Library
We present a clinimetric assessment of the Movement Disorder Society (MDS)‐sponsored
revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS). The MDS‐UDPRS …

[HTML][HTML] A randomized trial of deep-brain stimulation for Parkinson's disease

G Deuschl, C Schade-Brittinger, P Krack… - … England Journal of …, 2006 - Mass Medical Soc
Background Neurostimulation of the subthalamic nucleus reduces levodopa-related motor
complications in advanced Parkinson's disease. We compared this treatment plus …

Second consensus statement on the diagnosis of multiple system atrophy

S Gilman, GK Wenning, PA Low, DJ Brooks… - Neurology, 2008 - AAN Enterprises
Background: A consensus conference on multiple system atrophy (MSA) in 1998
established criteria for diagnosis that have been accepted widely. Since then, clinical …

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on …

CG Goetz, W Poewe, O Rascol, C Sampaio… - Movement …, 2004 - Wiley Online Library
Abstract The Movement Disorder Society Task Force for Rating Scales for Parkinson's
disease (PD) prepared a critique of the Hoehn and Yahr scale (HY). Strengths of the HY …

Challenges in the diagnosis of Parkinson's disease

E Tolosa, A Garrido, SW Scholz, W Poewe - The Lancet Neurology, 2021 - thelancet.com
Parkinson's disease is the second most common neurodegenerative disease and its
prevalence has been projected to double over the next 30 years. An accurate diagnosis of …

[HTML][HTML] Rivastigmine for dementia associated with Parkinson's disease

M Emre, D Aarsland, A Albanese… - … England Journal of …, 2004 - Mass Medical Soc
Background Cholinergic deficits are prominent in patients who have dementia associated
with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor …